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recommend (9), screening of HIV-infected patients who 
are sexually active with multiple partners should be con-
ducted every 3–6 months for early detection of syphilis 
and initiation of proper treatment to prevent transmission 
and progression to late syphilis.
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To the Editor: African tick-bite fever (ATBF) is a well 
known disease in travelers to sub-Saharan Africa (1). The 
causative agent, Rickettsia africae, is transmitted to hu-
mans by ticks of the genus Amblyomma (1,2). R. africae 
has been isolated or detected in ticks, humans, or both in 
22 sub-Saharan countries (3). Most ATBF cases have been 
described in tourists returning from countries to which it 
is endemic, most often from South Africa, Zimbabwe, and 
Botswana (4). We report a case of ATBF in a Slovenian 
traveler returning from Uganda.
In June 2015, a 29-year-old Slovenian man without un-
derlying illnesses sought care at the Department of Infectious 
Diseases, University Medical Centre Ljubljana (Ljubljana, 
Slovenia). He had a 1-day history of fever up to 38°C without 
chills, 5 days after returning from a 2-week trip to Uganda. 
He had received vaccines against yellow fever and viral hep-
atitis A before traveling and did not use antimalarial prophy-
laxis during his stay in southwestern Uganda. A day before he 
left Uganda, he noticed a tick bite on his left upper abdomen.
At initial examination, he appeared well. He had a 
temperature of 37.8°C, pulse rate 75 beats/min, and blood 
pressure 120/80 mm Hg. Skin examination was remarkable 
for a solitary papular lesion at the site of tick bite surround-
ed by a small erythematous halo associated with discrete 
lymphangitic streaking and painful enlarged left axillar 
lymph nodes. Results of initially performed routine labora-
tory tests were normal.
On day 5 of illness, the man was still febrile, with a 
temperature up to 39°C. Papular skin lesion had developed 
a dark brown crusted center (compatible with a tache noire), 
and some new discrete asymptomatic pale papular skin le-
sions appeared on his left leg and arm. Repeat laboratory 
testing indicated only mildly increased serum C-reactive 
protein (16.0 mg/L [reference <5 mg/L]).
The clinical course improved rapidly after treatment 
began with doxycycline. Fever resolved in 2 days, and en-
larged lymph nodes and skin lesions resolved completely 
within 14 days.
Microbiological procedures to detect for infection with 
tick-transmitted pathogens were performed to elucidate the 
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cause of the illness. The PCR for amplification of a 470-bp 
fragment of citrate synthase gene was performed according 
to a previously published protocol (5). DNA was extracted 
with QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany) 
from whole blood and the crust of the eschar collected on 
day 5 of illness. In addition, serum samples were tested by 
indirect immunofluorescent assay for specific IgG and IgM 
against Francisella tularensis and Rickettsia spp. (spotted 
fever and typhus group) 5 days and 10 weeks after onset 
of fever.
Diagnosis of ATBF was affirmed by positive PCR re-
sult from the crust of the eschar; further sequence analy-
sis revealed the infection with R. africae. Serologic test-
ing demonstrated seroconversion of IgG to R. conorii and 
R. rickettsii, which cross-reacts with R. africae (negative 
immunofluorescent assay IgG titer at initial testing and 
1:1,024 for R. conorii and R. rickettsii 10 weeks later) (6). 
Thick and thin blood smears were negative for malaria.
ATBF is the second most well-established cause of 
febrile illness among travelers to sub-Saharan Africa, af-
ter malaria. Usually it manifests by fever (59%–100% of 
cases), headache (62%–83%), eschar (53%–100%), lymph-
adenopathy (43%–100%), and rash (15%–46%). The clini-
cal and laboratory findings in the patient reported here were 
similar to those previously reported among R. africae–in-
fected patients (1). In the acute phase of illness, a biopsy 
and culture from an eschar, as well as PCR, are the most 
suitable methods to confirm the ATBF diagnosis. In this 
case, ATBF was proven by PCR and subsequent sequenc-
ing from a crust sample but not from whole blood and se-
roconversion of IgG.
The first information about R. africae in ticks in Ugan-
da was published in 2013 by Lorusso et al. (7), but previ-
ously R. conorii also was found (8). The prevalence rate of 
R. africae infection among Amblyomma variegatum ticks in 
Uganda was 97.1% (9). Recently, Proboste et al. established 
the presence of previously undetected tickborne pathogens 
in rural dogs and associated ticks in Uganda. Tick species 
Haemaphysalis leachi, Rhipicephalus spp., and A. varie-
gatum were infected by Rickettsia spp. (18.9%), including 
R. conorii and R. massiliae; by Ehrlichia spp. (18.9%), in-
cluding E. chaffeensis; and by Anaplasma platys (10).
Our MEDLINE literature search found no previous 
descriptions of human R. africae infection in Uganda. This 
case indicates that ATBF should be included as a possible 
diagnosis in persons with febrile illness who have traveled 
to Uganda, a well-known tourist destination.
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